GoodRx Holdings, Inc. (GDRX)
2.565
+0.04
(+1.79%)
USD |
NASDAQ |
May 21, 16:00
2.565
0.00 (0.00%)
After-Hours: 19:54
GoodRx Holdings Research and Development Expense (TTM) : 119.99M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| American Well Corp. | 62.87M |
| DarioHealth Corp. | 12.07M |
| Retrieve Medical Holdings, Inc. | -- |
| Claritev Corp. | -- |
| Certara, Inc. | 42.80M |